Unprecedented carbonic anhydrase inhibition mechanism: Targeting histidine 64 side chain through a halogen bond
Archiv der Pharmazie · 2025
DOI: 10.1002/ardp.202400776 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Roberto Paciotti und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy. Hauptthemen laut MEDLINE: Carbonic Anhydrase Inhibitors, Histidine, Halogens. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: None.
Abstract (Originalsprache)
2,2′‐Thio‐bis(4,6‐dichlorophenol), namely bithionol, is a small molecule endowed with a multifaceted bioactivity. Its peculiar polychlorinated phenolic structure makes it a suitable candidate to explore its potentialities in establishing interaction patterns with enzymes of MedChem interest, such as the human carbonic anhydrase (hCA) metalloenzymes. Herein, bithionol was tested on a panel of specific hCAs through the stopped‐flow technique, showing a promising micromolar inhibitory activity for the hCA II isoform. X‐ray crystallographic studies revealed an unprecedented halogen‐bond interaction between one chlorine of bithionol and the N3(ε) atom of the hCA II catalytically active histidine residue, His64. Then, quantum mechanics calculations based on the fragment molecular orbital method allowed us to estimate the strength of this bond (~2.9 kcal/mol) and highlighted the contribution of a rich hydrophobic interaction network within the isoenzyme. Interestingly, the compound inactivity against the hCA III isoform, characterized by His64Lys and Leu198Phe mutations, supported the key role played by halogen bonding in the enzyme affinity. This finding might pave the way for the development of a new class of hCA inhibitors characterized by such chemical features, with the halogen bond being a key ligand–receptor interaction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
- Section of Pharmaceutical and Nutraceutical Sciences, Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Sesto Fiorentino, Firenze, Italy.
- Department of Pharmacy, University of Pisa, Pisa, Italy.
- Department of Chemistry "Ugo Schiff", University of Florence, Sesto Fiorentino, Florence, Italy.
Förderung
- None
Zitieren
APA
Paciotti, R., Carradori, S., Angeli, A., D'Agostino, I., Ferraroni, M., Coletti, C., & Supuran, C. T. (2025). Unprecedented carbonic anhydrase inhibition mechanism: Targeting histidine 64 side chain through a halogen bond. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400776
Vancouver
Paciotti R, Carradori S, Angeli A, D'Agostino I, Ferraroni M, Coletti C, et al. Unprecedented carbonic anhydrase inhibition mechanism: Targeting histidine 64 side chain through a halogen bond. Archiv der Pharmazie. 2025. doi:10.1002/ardp.202400776
BibTeX
@article{Paciotti2025,
author = {Paciotti, Roberto and Carradori, Simone and Angeli, Andrea and D'Agostino, Ilaria and Ferraroni, Marta and Coletti, Cecilia and Supuran, Claudiu T},
title = {Unprecedented carbonic anhydrase inhibition mechanism: Targeting histidine 64 side chain through a halogen bond},
journal = {Archiv der Pharmazie},
year = {2025},
doi = {10.1002/ardp.202400776}
}
EUVIMED